INSIDER
Michigan health officials urge COVID vaccine booster doses for those eligible: Here’s what to know
Read full article: Michigan health officials urge COVID vaccine booster doses for those eligible: Here’s what to knowMichiganders who are eligible to receive a COVID-19 vaccine booster dose are urged to do so now.
Michigan health officials urge J&J, Moderna COVID vaccine booster doses for those eligible: Here’s what to know
Read full article: Michigan health officials urge J&J, Moderna COVID vaccine booster doses for those eligible: Here’s what to knowMichiganders who are eligible to receive a COVID-19 vaccine booster dose from Johnson & Johnson or Moderna are urged to do so now.
FDA inspection found problems at factory making J&J vaccine
Read full article: FDA inspection found problems at factory making J&J vaccineU.S. regulators say the Baltimore factory contracted to make Johnson & Johnson’s COVID-19 vaccine was dirty, didn’t follow proper manufacturing procedures and had poorly trained staff.
Henry Ford to carry out phase 3 of COVID-19 vaccine trial in Metro Detroit
Read full article: Henry Ford to carry out phase 3 of COVID-19 vaccine trial in Metro DetroitHenry Ford Health System is partnering with Janssen Pharmaceuticals to carry out the third phase of a COVID-19 vaccine trial. The Metro Detroit health system is one of three sites in Michigan, and one of many around the world, that will test the “safety and efficacy” of a single dose of Janssen’s potential COVID-19 vaccine, also known as JNJ-78436735 or Ad26.COV2.S, officials said. The clinical study, also called the “ENSEMBLE trial," is recruiting individuals who are not immunocompromised to receive either a single dose of the investigational vaccine or a placebo. Participating health systems in the U.S. and around the world are expected to recruit about 60,000 adults to carry out the third phase of the COVID vaccine trial. Related NewsAstraZeneca to deliver vaccine trial data by year’s endFeds issue coverage plan for COVID-19 vaccine and treatmentsProtests in Brazil support president in anti-vaccine stanceNearly 2.4 million Michigan residents have received flu vaccine this season
Oklahoma rests case in opioid trial against drugmaker Johnson & Johnson
Read full article: Oklahoma rests case in opioid trial against drugmaker Johnson & JohnsonAsked whether she knew that Johnson & Johnson, if found liable in this case, might have to pay "upwards of $17 billion to abate the nuisance issue," Diesselhorst said, "I wasn't aware of that." Johnson & Johnson has denied any wrongdoing, saying it followed the law and acted appropriately in its marketing and promotion of opioids. With the state resting, Johnson & Johnson will now resume its defense. She said the company properly trained reps to educate doctors about opioids and said it would be "wrong" for Johnson & Johnson to target pill mills, women and veterans. Johnson & Johnson attorney Sabrina Strong leaped to object: "Your honor, we've seen this throughout the trial, and I would ask that it stop."